Dimensional Fund Advisors LP Has $2.43 Million Position in MeiraGTx Holdings plc (NASDAQ:MGTX)

Dimensional Fund Advisors LP trimmed its holdings in MeiraGTx Holdings plc (NASDAQ:MGTX) by 11.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 398,813 shares of the company’s stock after selling 51,081 shares during the period. Dimensional Fund Advisors LP’s holdings in MeiraGTx were worth $2,428,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently made changes to their positions in MGTX. Geode Capital Management LLC raised its holdings in shares of MeiraGTx by 16.4% in the 4th quarter. Geode Capital Management LLC now owns 570,646 shares of the company’s stock worth $3,475,000 after acquiring an additional 80,407 shares during the last quarter. JPMorgan Chase & Co. boosted its stake in MeiraGTx by 1.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 342,667 shares of the company’s stock valued at $1,429,000 after purchasing an additional 4,186 shares during the last quarter. Privium Fund Management B.V. increased its holdings in MeiraGTx by 5.2% during the 4th quarter. Privium Fund Management B.V. now owns 225,078 shares of the company’s stock worth $1,371,000 after purchasing an additional 11,118 shares in the last quarter. Barclays PLC raised its stake in shares of MeiraGTx by 107.1% in the third quarter. Barclays PLC now owns 147,827 shares of the company’s stock worth $618,000 after purchasing an additional 76,437 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. raised its stake in shares of MeiraGTx by 13.1% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 112,021 shares of the company’s stock worth $682,000 after purchasing an additional 12,961 shares during the last quarter. 67.48% of the stock is owned by institutional investors.

MeiraGTx Price Performance

MeiraGTx stock opened at $4.64 on Thursday. MeiraGTx Holdings plc has a 52 week low of $3.85 and a 52 week high of $8.75. The company’s 50 day moving average price is $6.34 and its two-hundred day moving average price is $6.35. The stock has a market cap of $370.97 million, a P/E ratio of -3.83, a P/E/G ratio of 0.37 and a beta of 1.30. The company has a quick ratio of 2.34, a current ratio of 2.34 and a debt-to-equity ratio of 0.86.

MeiraGTx (NASDAQ:MGTX) last issued its quarterly earnings results on Tuesday, May 13th. The company reported ($0.51) EPS for the quarter, missing analysts’ consensus estimates of ($0.38) by ($0.13). MeiraGTx had a negative return on equity of 146.38% and a negative net margin of 633.05%. The business had revenue of $1.93 million for the quarter, compared to the consensus estimate of $4.44 million. On average, equities analysts predict that MeiraGTx Holdings plc will post -1.48 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on MGTX. Chardan Capital cut their target price on MeiraGTx from $38.00 to $35.00 and set a “buy” rating on the stock in a research report on Wednesday. Royal Bank of Canada lifted their price objective on shares of MeiraGTx from $11.00 to $13.00 and gave the stock an “outperform” rating in a report on Monday, March 17th.

Insider Activity

In other MeiraGTx news, CFO Richard Giroux sold 24,000 shares of MeiraGTx stock in a transaction dated Tuesday, April 22nd. The shares were sold at an average price of $6.00, for a total value of $144,000.00. Following the sale, the chief financial officer now owns 882,494 shares of the company’s stock, valued at approximately $5,294,964. The trade was a 2.65% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Alexandria Forbes sold 47,500 shares of the stock in a transaction that occurred on Tuesday, April 8th. The shares were sold at an average price of $5.34, for a total transaction of $253,650.00. Following the transaction, the chief executive officer now directly owns 1,408,983 shares of the company’s stock, valued at $7,523,969.22. This represents a 3.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 7.50% of the company’s stock.

About MeiraGTx

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases, neurodegenerative diseases, and xerostomia.